4//SEC Filing
HSU ERIC C 4
Accession 0001213900-21-053585
CIK 0001728328other
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 6:22 PM ET
Size
5.6 KB
Accession
0001213900-21-053585
Insider Transaction Report
Form 4
HSU ERIC C
Sr VP, Pre-Clinical Res/Dev
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-10-18+35,000→ 116,969 totalExercise: $1.40Exp: 2026-10-17→ Common shares (35,000 underlying)
Footnotes (1)
- [F1]The options were granted on 10/18/2021 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant.
Documents
Issuer
InMed Pharmaceuticals Inc.
CIK 0001728328
Entity typeother
Related Parties
1- filerCIK 0001817867
Filing Metadata
- Form type
- 4
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 6:22 PM ET
- Size
- 5.6 KB